The effect of transcranial direct current stimulation and inhibitory control training on depression and anxiety among post-stroke individuals

Table 3 Results of bayesian repeated measures ANOVA for PSD

Beck’s Depression Inventory (BDI)
Model Comparison					Post Hoc Comparison
Models	P(M\|data)	P(Incl\|data)	BF10	BFIncl	Levels		Prior Odds	Posterior Odds	BF_10,U	Error %
Null model	0.00		1.00		Pre-Post Factor
Pre-Post Factor	0.02	0.99	4.28	101.47	Level 1	Level 2	1.00	4.18	4.18	0.00
Condition	0.00	0.98	0.63	30.82	Condition
Pre-Post Factor + Condition	0.01	0.97	2.60	113.17	AT	T	0.59	0.55	0.93	0.01
Pre-Post Factor + Condition + Pre-Post Factor * Condition	0.97		240.69			A	0.59	0.71	1.20	0.01
Pre-Post Factor + Condition + Pre-Post Factor * Condition	0.97		240.69		T	A	0.59	0.19	0.32	0.01
Hamilton Depression Rating Scale (HAM-D)
Null model	0.01		1.00		Pre-Post Factor
Pre-Post Factor	0.10	0.97	16.44	20.03	Level 1	Level 2	1.00	18.35	18.35	0.00
Condition	0.03	0.90	4.42	5.76	Condition
Pre-Post Factor + Condition	0.69	0.18	115.86	0.89	AT	T	0.59	0.23	0.39	0.01
Pre-Post Factor + Condition + Pre-Post Factor * Condition	0.18		30.50			A	0.59	171.61	292.16	0.00
Pre-Post Factor + Condition + Pre-Post Factor * Condition	0.18		30.50		T	A	0.59	7.65	13.02	0.00

The Hamilton Depression Rating Scale (HAM-D) and Beck’s Depression Inventory (BDI) outcomes of the Bayesian Repeated Measures ANOVA are summarized in the table. The models assess the effects of Pre-Post Factor, Condition, and their interaction on scores, reporting posterior probabilities P(M∣data), inclusion probabilities P(Incl∣data), Bayes factors (BF10), and inclusion Bayes factors (BFIncl). For BDI, the most robust model includes the Pre-Post Factor and Condition interaction (BF10 = 240.69), while the Pre-Post Factor model for HAM-D shows significant effects (BF10 = 115.86). Post-hoc comparisons reveal pairwise group differences using adjusted posterior odds and Bayes factors. These findings highlight the influence of treatment conditions and pre-post changes on depressive symptoms. Abbreviations: Active tDCS treatment (A), sham tDCS treatment with ICCT (T), active tDCS treatment with ICCT (AT)

ISSN: 1471-2377